Pfizer Buy Pushes Double-Digit Growth For J&J Consumer Product Sales
This article was originally published in The Tan Sheet
Executive Summary
Johnson & Johnson's consumer products sales jumped 48.5 percent to $3.49 billion in the firm's first fiscal quarter since closing its acquisition of Pfizer Consumer Healthcare